«Luteolin offers novel therapeutic regimen in rotenone-induced Parkinson disease via modulation of TNF-α/FXMRP/serotonin/tyrosine hydroxylase signaling pathway», NJPS, т. 40, вып. 2, сс. 251–262, дек. 2025, doi: 10.54548/.